Astrazeneca Plc Stock Price Patterns
| AZNCF Stock | USD 187.45 3.13 1.70% |
Momentum 46
Impartial
Oversold | Overbought |
Using AstraZeneca PLC hype-based prediction, you can estimate the value of AstraZeneca PLC from the perspective of AstraZeneca PLC response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AstraZeneca PLC to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying AstraZeneca because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AstraZeneca PLC after-hype prediction price | USD 187.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AstraZeneca |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AstraZeneca PLC After-Hype Price Density Analysis
As far as predicting the price of AstraZeneca PLC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AstraZeneca PLC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of AstraZeneca PLC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AstraZeneca PLC Estimiated After-Hype Price Volatility
In the context of predicting AstraZeneca PLC's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AstraZeneca PLC's historical news coverage. AstraZeneca PLC's after-hype downside and upside margins for the prediction period are 185.32 and 189.58, respectively. We have considered AstraZeneca PLC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AstraZeneca PLC is very steady at this time. Analysis and calculation of next after-hype price of AstraZeneca PLC is based on 3 months time horizon.
AstraZeneca PLC Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as AstraZeneca PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AstraZeneca PLC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AstraZeneca PLC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.13 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
187.45 | 187.45 | 0.00 |
|
AstraZeneca PLC Hype Timeline
AstraZeneca PLC is presently traded for 187.45. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. AstraZeneca is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.14%. %. The volatility of related hype on AstraZeneca PLC is about 0.0%, with the expected price after the next announcement by competition of 187.45. About 49.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.37. AstraZeneca PLC last dividend was issued on the 23rd of February 2023. Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out AstraZeneca PLC Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in AstraZeneca Pink Sheet please use our How to Invest in AstraZeneca PLC guide.AstraZeneca PLC Related Hype Analysis
Having access to credible news sources related to AstraZeneca PLC's direct competition is more important than ever and may enhance your ability to predict AstraZeneca PLC's future price movements. Getting to know how AstraZeneca PLC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AstraZeneca PLC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RHHVF | Roche Holding AG | 0.00 | 0 per month | 1.76 | 0.21 | 4.34 | (2.78) | 15.96 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.77 | 0.26 | 3.60 | (1.47) | 13.68 | |
| RHHBF | Roche Holding AG | 0.00 | 0 per month | 1.96 | 0.18 | 6.48 | (4.30) | 19.30 | |
| NVSEF | Novartis AG | 0.00 | 0 per month | 2.25 | 0.09 | 5.21 | (5.11) | 15.54 | |
| NONOF | Novo Nordisk AS | 0.00 | 0 per month | 0.00 | (0.02) | 6.71 | (5.56) | 27.29 | |
| SRTOY | Sartorius Stedim Biotech | 0.00 | 0 per month | 0.00 | (0.05) | 4.82 | (4.14) | 17.99 | |
| SNYNF | Sanofi | 0.00 | 0 per month | 0.00 | (0.08) | 2.83 | (3.28) | 8.58 | |
| FSNUY | Fresenius SE Co | 0.00 | 0 per month | 0.00 | (0.20) | 2.61 | (5.03) | 12.81 | |
| CHGCY | Chugai Pharmaceutical Co | 0.00 | 0 per month | 1.63 | 0.11 | 3.99 | (2.84) | 11.05 | |
| CHGCF | Chugai Pharmaceutical Co | 0.00 | 0 per month | 3.69 | 0.1 | 7.70 | (6.12) | 18.43 |
AstraZeneca PLC Additional Predictive Modules
Most predictive techniques to examine AstraZeneca price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca using various technical indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AstraZeneca PLC Predictive Indicators
The successful prediction of AstraZeneca PLC stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AstraZeneca PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AstraZeneca PLC based on analysis of AstraZeneca PLC hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AstraZeneca PLC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AstraZeneca PLC's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for AstraZeneca Pink Sheet analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |